Skip to main content
FinSpry Logo
FinSpry
LRMR logo
LRMR
(NASDAQ)
Larimar Therapeutics, Inc.
$4.79-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Larimar Therapeutics (LRMR) Stock Price & Financial Analysis

Larimar Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.51 - $4.80
52-Week High$6.42
52-Week Low$1.61
Open$4.57
Volume993.11K
Average Volume (3M)993.11K
Market Cap375.18M
Shares Outstanding78.32M
Price to Book (P/B)2.64
EV/EBITDA-2.01
50-Day MA$4.17
200-Day MA$3.83
52-Week Change134.00%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Larimar Therapeutics

What is the current stock price for LRMR?

As of the latest trading session, LRMR stock trades at $4.79. The 52-week range is $1.61–$6.42, with a day range of $4.51–$4.80.

What is the P/E ratio for LRMR?

The P/E ratio (Price-to-Earnings) for LRMR is shown in the Key Statistics section. This valuation metric helps compare Larimar Therapeutics, Inc. to industry peers.

Does LRMR pay dividends?

Larimar Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LRMR?

Based on 2 analysts, the consensus for LRMR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of LRMR?

Larimar Therapeutics's market capitalization is $375.2M, classifying it as a small-cap company. Larimar Therapeutics operates in the Healthcare sector within the Biotechnology industry.